CSI Market
Sign In | Register

Cannapharmarx Inc (CPMD) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access CPMD quarterly Cash Flow →
Quarterly cash flow trends provide additional context on Cannapharmarx Inc's liquidity and ability to support ongoing operations and capital needs.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-11.13
Depreciation & amortization0.00
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.26
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.14
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Loss, before Tax-0.07
Compensatory Loan Increase Decrease-
Increase Decrease In Accrued Interest Payable To Related Parties-
Gain Loss Related To Litigation Settlement-
Legal Settlement Payable In Stock-
Legal Settlement By Stock Issuance-
Increase Decrease In Note Discount-
Mortgage Loans On Real Estate Period Increase Decrease-
Acquisition Consideration Paid In Common Stock-
Derivative Gain Loss On Derivative Net0.85
Goodwill And Intangible Asset Impairment-
Change In Unrealized Gain Loss On Fair Value Hedging Instruments-
Advertising Expense Paid With Common Stock-
Beneficial Conversion Feature Of Convertible Notes-
Stock Issued In Connection With Financing-
Amortization And Depreciation Included In Cost Of Goods Sold1.96
Increase Decrease In Goods And Services Tax Receivable0.49
Income taxes0.00
Gain (Loss) on Investments0.00
Accounts Receivable1.87
Increase (Decrease) in Royalties Payable0.30
Increase (Decrease) in Interest Payable, Net0.00
Payments for (Proceeds from) Other Deposits0.00
Increase (Decrease) in Prepaid Expense0.00
Other Working Capital0.00
Other Noncash Expense0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities4.54
Discontinued operations0.00
Net Cash flow from Operating Activities-0.79
Investing Activities
Capital Expenditures-0.01
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payments For Deposits On Acquisitions And Prepaid Financing Costs-
Net Impact From Sale Of Ams Building Excluding Mortgage Payoff-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses and Interest in Affiliates0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.80
Discontinued operations0.00
Net Cash Flow from Investing Activities0.79
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.79
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.80
Debt Released In Acquisition Of Canna Colorado-
Shares Issued To Vendor In Prior Year Paid Par This Period-
Cash From Bank To Close Overdrawn Account-
Reduction Of Finance Lease Liability-
Proceeds From Issuance Of Common Stock In Connection With Financing-
Right Of Use Assets Net-
Proceeds From Commitment Shares Issued With Convertible Notes-
Proceeds From Beneficial Conversion Feature Of Convertible Notes-
Payments Made On Liability For Rightofuse Building-
Operating Lease Payments-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.01
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.79
Total Cash Flow0.00
4 historic quarters locked

Sign in to unlock the full Cannapharmarx Inc cash flow history.

Sign In Create Free Account

About Cannapharmarx Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 31, 2026
  • Source: canna_10k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001654954-26-003108

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License